Related Experiment Video
Updated: Jan 23, 2026

Visualizing the Effects of Oxidative Damage on Drosophila Egg Chambers using Live Imaging
Published on: April 10, 2021
PACAP Alleviates Paclitaxel-Induced Peripheral Neuropathy by Targeting Oxidative Stress and Mitochondrial Damage via
Ruyue Mo1, Chuanming Wang2, Haibei Hu3
1Department of Clinical Laboratory Medicine, Fifth Affiliated Hospital, Southern Medical University, Guangzhou, China.
Background:
Paclitaxel-induced peripheral neuropathy (PIPN) is a severe and dose-limiting side effect. This study investigated the therapeutic potential of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and its underlying mechanism.
Methods:
A murine PIPN model was established. Behavioral tests assessed neuropathic pain. Molecular and cellular analyzes, including western blot, ELISA, and transmission electron microscopy, evaluated oxidative stress, mitochondrial function, and key protein expression in dorsal root ganglia (DRG) and SH-SY5Y cells. The PGC-1α inhibitor SR-18292 was used for mechanistic validation.
Results:
High-dose PACAP (100 μg/kg) significantly alleviated PTX-induced mechanical allodynia and thermal/cold hyperalgesia. It reduced oxidative stress (lowered ROS/MDA, increased SOD) and restored mitochondrial function (improved membrane potential, ATP, and ultrastructure) in DRG neurons. PACAP upregulated PGC-1α and HO-1 expression, and its protective effects were abolished by PGC-1α inhibition. Crucially, PACAP did not interfere with PTX's antitumor efficacy.
Conclusion:
PACAP alleviates PIPN by activating the PGC-1α pathway to improve mitochondrial function and counteract oxidative stress, presenting a promising adjunct therapy that does not compromise chemotherapy.
Related Concept Videos
Nitric Oxide Signaling Pathway
Animal Mitochondrial Genetics
Oxidation Numbers
Export of Mitochondrial and Chloroplast Genes
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

